Endometriosis is a painful and chronic condition in which the uterus tissue grows inappropriately outside the uterus. Current treatments are limited and include the surgery and hormone therapy, which can lead to unwanted side effects. New research from Baylor College of Medicine, the University of Oxford, the University of Wisconsin-Madison and Bayer AG offers new insights into how to treatthis debilitating disease.
THE study results have been published in the scientific journal Science Translational Medicine.
Endometriosis: Here’s what the new research says
The team of scientists performed genetic analyzes on humans and rhesus macaques to identify a specific gene, NPSR1, which increases the risk for the women of being affected by endometriosis. The results reveal a potential new non-hormonal drug target that can lead to better therapy.
Read Also
- Covid, the study: similar pandemic risk may double in the coming decades Aug 31, 2021
- The power of the group – CULTURE SANG & OR Apr 13, 2021
- Nursing is a ‘top priority’ for the head of health-care recruitment in NS Oct 14, 2021
- Vaccines, Hope: “Today we will exceed 64 million doses administered” Jul 23, 2021
- Johnson & Johnson, “effective vaccine on Delta variant” Jul 15, 2021
- Salvini: “Vaccination obligation? I don’t want my 18-year-old son chased by a syringe” Jul 19, 2021
- Rospotrebnadzor assessed the duration of breathing problems after COVID-19 Aug 29, 2021